CLINICAL_TRIALS
trial_result
· 2012-03-27
Clinical Trial Update: Clinical Study to Evaluate the Pharmacokinetic Characteristics Between TMX-67 and Feburic® in Healthy Volunteers [Phase 1]
Summary
Phase 1 pharmacokinetic study comparing TMX-67 with Feburic (febuxostat) in healthy volunteers has been completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: SK Chemicals Co., Ltd. | Conditions: Gout | Phase 1 | Status: COMPLETED